The COVID Vaccine & Therapeutics Development's Effect on Future Drug Development & DCT's
There may never be another Operation Warp Speed, but are there strategies, tools, or tactics utilized during the rapid development of the COVID-19 vaccines and therapeutics that can be applied to drug development in other areas going forward? This panel of experts will explore that question and seek to identify how the drug development process can be improved to get new, safe and effective therapies and cures to patients faster.
|5/5/2022 2:00 PM
|5/5/2022 2:45 PM
Innovation and Access in Mental Health Care
Massachusetts Blue Cross Blue Shield Foundation recently released survey findings that more than 1 in 3 adults reported needing behavioral health care for themselves or a family member over the last 12 months but only 1 in 4 received care. Despite advancements in science, medicine, and technology in mental health care over the past 20 years, a significant gap remains in brain health. This panel will discuss the recent discoveries in mental health care delivery, access, and innovation including drug discovery and development, new medication management tools, telepsychiatry, and digital therapeutics.
|5/5/2022 2:45 PM
|5/5/2022 3:30 PM
Next Generation Therapeutics
The panel, “Next Generation Therapeutics,” will explore the therapeutics landscape as it continues to break new ground. In Massachusetts we have had a front row seat to the extraordinary success of the mRNA COVID-19 vaccines happening in real time on the world stage. As we come off an unprecedented year and look to the future, forecasts are predicting growth from a market of $5 billion in 2020 to $58 billion in 2026, according to the Evaluate Pharma consensus. Panelists will share the latest trends they are seeing, what therapies are experiencing rapid growth, who are the therapeutic leaders, and how the landscape will evolve over the next 12 months and the market respond.
|5/5/2022 3:45 PM
|5/5/2022 4:30 PM